BSE filing, NSE: CERA. Summary written from the filing by ALFA Finder's alert engine.
Cera Sanitaryware Ltd: key numbers
- Share price
- ₹4,775.40
- Market cap
- ₹6,159 Cr
- Revenue (annual)
- ₹2,050 Cr
- Net profit (annual)
- ₹204.2 Cr
- P/E (TTM)
- 30.4×Sector 43.1×
- Promoter holding
- 54.41%+0.00% QoQ
- FII holding
- 15.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cera Sanitaryware Ltd
All →Cera Sanitaryware Employee Stock Options
Cera Sanitaryware Ltd has granted 13,650 stock options to eligible employees under its ESOS 2024 scheme. The options feature a five-year vesting schedule and an exercise price set at the face value of Rs. 5 per share.
Cera Sanitaryware Management Change
Cera Sanitaryware's board approved re-appointment of Vikram Somany as CMD and Anandh Sundar as Independent Director for 5-year terms starting 2027. Both remain subject to shareholder approval.
Cera Sanitaryware Q2 FY27 Results: Net Profit ₹56.1 Cr, Down 0.9% YoY
Cera Sanitaryware Ltd reported revenue from operations of ₹603 Cr (+27.4% YoY) and net profit of ₹56.1 Cr (-0.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹56.1 Cr · -0.9% YoY
Cera Sanitaryware Board Meeting Date
Cera Sanitaryware scheduled a board meeting on 4 Nov 2026 to approve Q2/H1 results and re-appoint its CMD and an Independent Director. No financial figures or transaction values are disclosed in this intimation.
Cera Sanitaryware Other Announcement
Cera Sanitaryware filed a routine Regulation 74(5) certificate confirming the processing and listing of dematerialized shares for the quarter ended September 30, 2026.
Cera Sanitaryware Employee Stock Options
Cera Sanitaryware Employees Welfare Trust acquired 2,150 equity shares via market purchase. The transaction, valued at ₹1.21 Crore, increased the trust's holding to 0.05%.
- Value
- ₹1.21 Cr
Other results update announcements
All →Steel Exchange India Results Update
Steel Exchange India Ltd reported a nine-fold surge in Q2 FY27 PAT to ₹18 Crore. Revenue rose 46% to ₹343 Crore alongside a ₹102 Crore debt reduction.
- quarterly production
- 69617.42 MT
Alembic Pharmaceuticals Results Update
Alembic Pharmaceuticals reported Q2 FY27 revenue growth of 36% to ₹2,603 Crore. Net profit surged 81% to ₹335 Crore, driven by exceptional US business performance.
- Value
- ₹2,603 Cr
SJS Enterprises Results Update
S.J.S. Enterprises reported record quarterly revenue of Rs. 282.73 Crore, up 16.9% YoY. Net profit for Q2FY27 rose 34.8% YoY to Rs. 58.33 Crore.
- Value
- ₹282.7 Cr
Meghmani Organics Results Update
MOL reported Q2 FY27 revenue of ₹658.2 crore, up 18% YoY, with net profit of ₹45.3 crore. EBITDA margin eased to 10.8% on elevated input costs.
GPT Infraprojects Results Update
GPT Infraprojects reported Q2 FY27 revenue of ₹291.4 crore and PAT of ₹18.3 crore. Order inflow was ₹1,491 crore; interim dividend of ₹1 declared.
- Order book
- ₹5,373 Cr
Indo Count Industries Results Update
Indo Count reported record Q2 FY27 income of ₹1,699 Cr and PAT of ₹132 Cr. H1 EBITDA grew 73% YoY to ₹420 Cr.